Glaxosmithkline Pharmaceuticals has informed that pursuant to Regulation 30(6) of the Schedule III, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, it enclosed the transcript of the Analyst / Institutional Meeting held on 15th February 2024. The said transcript is also uploaded on the website of the Corporation and can be accessed through the link: https://india-pharma.gsk.com/en-in/investors/analyst-meets/.
The above information is a part of company’s filings submitted to BSE.
